Some patients want to take a holiday pause on weight-loss drugs. Here's what doctors say
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
Some patients want to take a holiday pause on diabetes or weight-loss drugs. Here's what doctors say
Around the holidays, when many people are baking cookies for Santa, enjoying cocktail parties or having festive family feasts ...
24/7 Wall St2h
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...
McKnight's Long-Term Care News9h
FDA says shortage of GLP-1 tirzepatide is over
The US Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over.
i12h
The medical breakthroughs to watch out for in 2025
New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Everyday Health22h
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...